The unprecedented rapid deployment of mRNA vaccines against COVID-19 can be traced back to the early studies of RNA nanocarriers, including the study by Zimmerman which showcased the effectiveness of RNA nanocarriers in vivo. This study, among others, ultimately resulted in Onpattro, the first FDA-approved RNA formulation.
- SEO Powered Content & PR Distribution. Get Amplified Today.
- Platoblockchain. Web3 Metaverse Intelligence. Knowledge Amplified. Access Here.
- Source: https://www.cell.com/trends/biotechnology/fulltext/S0167-7799(22)00347-X?rss=yes
More from Biotechnology Trends
Microfluidics: the propellant of CRISPR-based nucleic acid detection
Source Node: 1893468
Time Stamp: Aug 18, 2022
Economical downstream processing of microbial polyunsaturated fatty acids
Source Node: 1922520
Time Stamp: Jan 26, 2023
Animal Immunization, in Vitro Display Technologies, and Machine Learning for Antibody Discovery
Source Node: 802518
Time Stamp: Mar 25, 2021
Comparison of CRISPR/Cas and Argonaute for nucleic acid tests
Source Node: 1780650
Time Stamp: Dec 5, 2022
Advances in cell coculture membranes recapitulating in vivo microenvironments
Source Node: 1890236
Time Stamp: Aug 24, 2022
Engineering biology for sustainable 1,4-butanediol synthesis
Source Node: 1915347
Time Stamp: Jan 23, 2023
Synthetic biology for plant genetic engineering and molecular farming
Source Node: 2042801
Time Stamp: Mar 31, 2023
Design of erythrocyte-derived carriers for bioimaging applications
Source Node: 1888697
Time Stamp: Aug 26, 2022
Harnessing synthetic biology to develop novel psychedelic therapies
Source Node: 1788375
Time Stamp: Dec 23, 2022
Agricultural biotechnology for sustainable food security
Source Node: 1927784
Time Stamp: Jan 27, 2023
Biosensors for healthcare: current and future perspectives
Source Node: 1783309
Time Stamp: Dec 23, 2022
Orally delivered single-domain antibodies against gastrointestinal pathogens
Source Node: 1950221
Time Stamp: Feb 9, 2023